Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
23.50    0.00 (0.00%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £11.19m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Trading Update

3 Feb 2020 07:00

RNS Number : 6618B
Pennant International Group PLC
03 February 2020
 

 

FOR IMMEDIATE RELEASE 3 February 2020 

PENNANT INTERNATIONAL GROUP PLC

 

Trading Update

 

 

Pennant International Group plc ("Pennant", the "Group", or the "Company"), the AIM quoted supplier of integrated training and support solutions, products and services which train and assist operators and maintainers in the defence and regulated civilian sectors, announces the following trading update in respect of its financial year ending 31 December 2019 ("FY2019"). The Group's audited results for FY2019 are scheduled to be released on 23 March 2020.

 

Preliminary unaudited assessment of the Group's trading for FY2019 indicates that Pennant will report:

 

·; Revenues of circa £20 million;

·; Underlying earnings before interest, taxation and amortisation (EBITA) of circa £1.6 million;

·; Underlying earnings before interest, taxation, depreciation and amortisation (EBITDA) of circa £2.4 million;

·; Net debt at year-end of £2.2 million;

·; Three-year order book at year-end of £33 million of which circa £16 million is scheduled for delivery in 2020.

 

Underlying EBITA is stated after the add-back of a one-off restructuring expense and a charge relating to the impairment of the Group's freehold property portfolio (amounting to £0.7 million and £0.8 million respectively) both described in more detail below.

 

Impairment of freehold properties

 

In order to gear up for major contracts, the Group invested over £3 million in freehold property. The properties acquired are currently being utilised on the Qatar programme and on the helicopter maintenance trainer contract announced on 31 October 2019 and are necessary for the further expansion of the business.

 

Following a revaluation for the purposes of the annual accounts, it has become apparent that, due to the general softening of the commercial property market both locally and more broadly, certain of the properties are currently overvalued in the Company's books. While the net effect of the revaluation across Pennant's freehold portfolio is a reduction of £0.4 million (being an impairment of £0.8 million against certain properties and an increase in value of £0.4 million against others), due to applicable accounting standards the Group is required to expense the gross amount of the impairment (£0.8 million), which is regarded as non-underlying, with the upwards revaluations being credited to reserves.

 

Restructuring expense

 

As outlined in its announcement of 2 May 2019, the Group has been implementing a wide-ranging cost reduction exercise and various roles have been removed from the business. The aggregate cost associated with terminations of employment resulting from this exercise is £0.7 million which is regarded as a non-underlying expense.

 

It is anticipated that this programme will realise gross annualised savings of over £1 million. Taking into account new roles and capabilities implemented in the revised structure, the net annualised cost saving will be circa £0.6 million.

 

Strategy and Outlook

 

The Group continues to focus on its strategic objective of increasing the proportion of its revenues which derive from software and services, particularly those of a recurring nature.

 

Recent steps taken include an agreement to acquire Absolute Data Group (announced on 21 January 2020) which will form part of an enlarged, enhanced 'Integrated Logistics Support' offering as well as providing an increased presence in Pennant's target growth markets of North America and Australasia.

 

Pennant is actively considering other strategic opportunities to partner with or acquire complementary businesses and will continue to invest in developing its product range and its ability to deliver complementary services.

 

With a contracted order book of £33 million scheduled for delivery over the next three years, together with a sizeable pipeline of single-source opportunities, the Board remains confident of future prospects and of building and delivering long-term shareholder value.

 

 

 

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director

+44 (0) 1452 714 914

WH Ireland Limited (Nomad and Broker)

www.whirelandcb.com

Mike Coe

Chris Savidge

+44 (0) 117 945 3470

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKBBNDBKBCBK
Date   Source Headline
24th Sep 20247:00 amRNSDirector Dealing
23rd Sep 20247:00 amRNSInterim Results
19th Sep 20243:30 pmRNSNotice of Interim Results
3rd Sep 202411:00 amRNSIssue of Equity, Director Dealings & TVR
3rd Sep 20247:00 amRNSAppointment of NED & Interim CFO
14th Aug 20247:00 amRNSDirectorate Change
13th Aug 20245:20 pmRNSHolding(s) in Company
6th Aug 20241:36 pmRNSDirectors’ Dealings
2nd Aug 20247:00 amRNSDirectors’ Subscriptions
25th Jul 20247:00 amRNSTrading Update
17th Jul 202411:42 amRNSResult of AGM
17th Jul 20247:00 amRNSDirector Appointment & Notice of Trading Update
15th Jul 20247:00 amRNSChange of Adviser
25th Jun 202410:27 amRNSNotice of AGM & Posting of Accounts
21st Jun 20247:00 amRNS2023 Final Results
13th Jun 20245:41 pmRNSHolding(s) in Company
31st May 20244:32 pmRNSHolding(s) in Company
24th May 20247:00 amRNSResult of Placing and Subscription
23rd May 20244:30 pmRNSProposed Fundraising
14th May 20247:00 amRNSBusiness Update & Board Change
24th Apr 20242:44 pmRNSNotice of Results and Appointment of Board Adviser
7th Feb 20247:00 amRNSAppointment of Non-executive Director
7th Feb 20247:00 amRNSYear-End Trading Update
22nd Nov 202311:41 amRNSHolding(s) in Company
15th Nov 20235:20 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20237:00 amRNSNew Strategic Partnership
7th Sep 20237:00 amRNSPennant attending DSEI, London
19th Jul 20237:00 amRNSTrading Update & Notice of Interim Results
10th Jul 202310:39 amRNSIssue of Equity, Director Dealings & TVR
13th Jun 20237:00 amRNSBusiness Update: New Contract Wins
7th Jun 202310:40 amRNSResult of AGM
23rd May 202310:45 amRNSHolding in Company
22nd May 20233:15 pmRNSHolding in Company
16th May 202312:21 pmRNSHolding in Company
27th Apr 202311:31 amRNSNotice of AGM & Posting of 2022 Annual Accounts
26th Apr 20237:00 amRNS2022 Final Results
20th Apr 20237:00 amRNSNotice of 2022 Final Results
13th Apr 20237:00 amRNSAcquisition of UK Rail Services Business
16th Mar 20232:00 pmRNSHolding(s) in Company
14th Mar 20235:30 pmRNSHolding(s) in Company
23rd Feb 20231:13 pmRNSAppointment of Chair
8th Feb 202311:05 amRNSSecond Price Monitoring Extn
8th Feb 202311:00 amRNSPrice Monitoring Extension
8th Feb 20237:00 amRNSYear-end Trading Update
19th Jan 20239:31 amRNSHolding(s) in Company
12th Jan 202312:47 pmRNSAppointment of Director
9th Nov 20227:00 amRNSShare Option Restructuring
24th Oct 20228:31 amRNSDirectorate Change
21st Sep 20227:00 amRNS2022 Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.